General MedicationsOPHTHALMICStandard
DURYSTA
BIMATOPROST
Standard Dose
10MCG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview DURYSTA is listed in Drugs@FDA under application 211911 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BIMATOPROST Form and strength IMPLANT;OPHTHALMIC - 10MCG Sponsor ABBVIE Submission history Latest submission status date: 2024-10-10 00:00:00.
Structured Monograph
Clinical summary
Approval overview DURYSTA is listed in Drugs@FDA under application 211911 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BIMATOPROST Form and strength IMPLANT;OPHTHALMIC - 10MCG Sponsor ABBVIE Submission history Latest submission status date: 2024-10-10 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.